MAZINDOL IN THE TREATMENT OF PARKINSONS-DISEASE

被引:17
作者
DELWAIDE, PJ [1 ]
MARTINELLI, P [1 ]
SCHOENEN, J [1 ]
机构
[1] UNIV LIEGE,DEPT INTERNAL MED,NEUROL & CLIN NEUROPHYSIOL SECT,B-4000 LIEGE,BELGIUM
关键词
D O I
10.1001/archneur.1983.04050120038004
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
引用
收藏
页码:788 / 790
页数:3
相关论文
共 14 条
[1]  
BARBEAU A, 1969, CAN MED ASSOC J, V101, P791
[2]   MODIFICATION OF PARKINSONISM - CHRONIC TREATMENT WITH L-DOPA [J].
COTZIAS, GC ;
PAPAVASI.PS ;
GELLENE, R .
NEW ENGLAND JOURNAL OF MEDICINE, 1969, 280 (07) :337-&
[3]   VERTEILUNG VON NORADRENALIN UND DOPAMIN (3-HYDROXYTYRAMIN) IM GEHIRN DES MENSCHEN UND IHR VERHALTEN BEI ERKRANKUNGEN DES EXTRAPYRAMIDALEN SYSTEMS [J].
EHRINGER, H ;
HORNYKIEWICZ, O .
KLINISCHE WOCHENSCHRIFT, 1960, 38 (24) :1236-1239
[4]  
GOGERTY JH, 1975, ARCH INT PHARMACOD T, V214, P285
[5]  
GOMZE G, 1975, CLIN TRIALS J, V12, P38
[6]   PARKINSONISM - ONSET PROGRESSION AND MORTALITY [J].
HOEHN, MM ;
YAHR, MD .
NEUROLOGY, 1967, 17 (05) :427-&
[7]  
LEES AJ, 1975, LANCET, V2, P709
[8]   ANALYSIS OF THE CLINICAL PROBLEMS IN PARKINSONISM AND THE COMPLICATIONS OF LONG-TERM LEVODOPA THERAPY [J].
LESSER, RP ;
FAHN, S ;
SNIDER, SR ;
COTE, LJ ;
ISGREEN, WP ;
BARRETT, RE .
NEUROLOGY, 1979, 29 (09) :1253-1260
[9]   TREATMENT OF PARKINSONS-DISEASE WITH BROMOCRIPTINE [J].
LIEBERMAN, A ;
KUPERSMITH, M ;
ESTEY, E ;
GOLDSTEIN, M .
NEW ENGLAND JOURNAL OF MEDICINE, 1976, 295 (25) :1400-1404
[10]  
MARSDEN CD, 1977, LANCET, V1, P345